All-incl. Parkinson protocol (16 Nights)

Service Description

This package is designed for Parkinson's disease patients with a caregiver. For the patient we offer a comfortable room and two daily meals. For the caregiver a basic accommodation is included only. The therapeutic target with Ibogaine is a sustained GDNF upregulation to support dopaminergic neuron survival and regeneration. A single dose produces a GDNF spike that dissipates within days. Our protocol is engineered to extend and amplify this window. The TA booster phase (Days 3–9) uses twice‑daily doses of ibogaine total alkaloid extract. Each dose contributes to a progressive buildup of noribogaine, the long‑acting metabolite primarily responsible for GDNF expression. By the time of the HCl flood session on Day 10, noribogaine levels have been elevated for a full week, creating a sustained neurotrophic environment that a single‑session approach cannot achieve. The post‑session microdosing phase (Days 12–16) then extends GDNF signaling further, bridging into the at‑home microdosing protocol patients follow for 30 days post‑discharge. The result is weeks of continuous neurotrophic support rather than a single peak event. Synergistic Supportive Therapies The medicine in the TA booster phase is strategically delivered within the float tank and HBOT chamber. Delivering the ibogaine doses within these modalities ensures that the brain receives both the pharmacological signal and the metabolic resources to respond, enhancing neuronal regeneration. Floatation therapy, with its zero‑gravity sensory deprivation, reduces cortisol, encourages theta brainwave states, and enhances parasympathetic tone—creating an optimal neural environment for ibogaine's neuroplastic and introspective work. HBOT concurrently elevates tissue oxygen tension, stimulates angiogenesis, supports mitochondrial function, and reduces neuroinflammation, working in direct synergy with GDNF upregulation to fuel cellular repair and clear protein aggregates. Our wood-fired Finnish sauna is available daily at 5pm, providing heat‑shock protein expression, improved cerebral blood flow, and systemic detoxification for both the patient and the caregiver.